Old Web
English
Sign In
Acemap
>
authorDetail
>
Laurel A. Menapace
Laurel A. Menapace
National Institutes of Health
Cell
Medicine
Disease
Pharmacology
disease management
3
Papers
11
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Mitapivat (AG-348) Demonstrates Safety, Tolerability, and Improvements in Anemia, Hemolysis, Oxygen Affinity, and Hemoglobin S Polymerization Kinetics in Adults with Sickle Cell Disease: A Phase 1 Dose Escalation Study
2021
Blood
Julia Z. Xu
Anna Conrey
Ingrid Frey
Eveline Gwaabe
Laurel A. Menapace
Laxminath Tumburu
Maureen Lundt
Quan Li
Kristen E Glass
Varsha Iyer
Heidi Mangus
Charles Kung
Lenny Dang
Penelope A. Kosinski
Peter Hawkins
Neal Jeffries
William W. Eaton
Swee Lay Thein
Show All
Source
Cite
Save
Citations (0)
COVID-19 and sickle cell disease.
2020
Haematologica
Laurel A. Menapace
Swee Lay Thein
Show All
Source
Cite
Save
Citations (10)
Phase 1 Multiple Ascending Dose Study of Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Mitapivat (AG-348) in Subjects with Sickle Cell Disease
2020
Blood
Julia Z. Xu
Anna Conrey
Ingrid Frey
James S. Nichols
Laurel A. Menapace
Laxminath Tumburu
Timothy Lequang
Quan Li
Emily B. Dunkelberger
Eric R. Henry
Troy Cellmer
Varsha Iyer
Heidi Mangus
Charles Kung
Lenny Dang
Penelope A. Kosinski
Peter Hawkins
Neal Jeffries
William A. Eaton
Swee Lay Thein
Show All
Source
Cite
Save
Citations (1)
1